CD4 and prostate cancer: To examine the effect of GILT on the Ag presenting capacity of the prostate cancer cell line CWR22Rv1 to CD4+ T cells, CWR22 and CWR22.GILT cells were cocultured with HLA-DR-restricted PSMA-specific CD4+ T cells for 48 h.